What Medtronic plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 15 |
| Total trades | 20 | 76 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 76 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Marinaro Michael | EVP, Pres MedSurg and Americas | Aug 20 | Withheld — tax / exercise cost · F | −1,084 | $92.30 | −$100K | 116,336 |
| Martha Geoffrey | Chairman and CEO | Aug 03 | Grant / award · A | +41,533 | — | — | 327,866 |
| Kiil Harry Skip | EVP & President Cardiovascular | Aug 03 | Grant / award · A | +9,230 | — | — | 43,669 |
| Quinn Michelle | EVP, GC and Secretary | Aug 03 | Grant / award · A | +6,346 | — | — | 26,721 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | Aug 03 | Grant / award · A | +46,147 | — | — | 117,420 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | Aug 03 | Grant / award · A | +10,960 | — | — | 71,273 |
| Walter Matthew R. | SVP, Chief HR Officer | Aug 03 | Grant / award · A | +5,769 | — | — | 39,928 |
| Blomquist Denise L. | Chief Accounting Officer | Aug 03 | Grant / award · A | +2,337 | — | — | 16,998 |
| Pieton Thierry | EVP & Chief Financial Officer | Aug 03 | Grant / award · A | +11,537 | — | — | 49,645 |
| Thompson Kweli | EVP & President, Neuroscience | Aug 03 | Grant / award · A | +6,923 | — | — | 35,390 |
| Martha Geoffrey | Chairman and CEO | Jul 31 | Withheld — tax / exercise cost · F | −15,810 | $85.39 | −$1.35M | 286,333 |
| Kiil Harry Skip | EVP & President Cardiovascular | Jul 31 | Withheld — tax / exercise cost · F | −3,074 | $85.39 | −$262K | 34,439 |
| Marinaro Michael | EVP, Pres MedSurg and Americas | Jul 31 | Withheld — tax / exercise cost · F | −3,356 | $85.39 | −$287K | 60,313 |
| Walter Matthew R. | SVP, Chief HR Officer | Jul 31 | Withheld — tax / exercise cost · F | −1,675 | $85.39 | −$143K | 34,159 |
| Blomquist Denise L. | Chief Accounting Officer | Jul 31 | Withheld — tax / exercise cost · F | −212 | $85.39 | −$18.1K | 14,661 |
| Thompson Kweli | EVP & President, Neuroscience | Jul 31 | Withheld — tax / exercise cost · F | −1,739 | $85.39 | −$148K | 28,467 |
| Quinn Michelle | EVP, GC and Secretary | Jul 28 | Withheld — tax / exercise cost · F | −2,069 | $86.88 | −$180K | 20,375 |
| Walter Matthew R. | SVP, Chief HR Officer | Jul 08 | Open-market sale · S | −3,102 | $83.15 | −$258K | 35,694 |
| Kiil Harry Skip | EVP & President Cardiovascular | Jun 08 | Open-market sale · S | −228 | $80.45 | −$18.3K | 37,227 |
| Kiil Harry Skip | EVP & President Cardiovascular | Jun 08 | Open-market sale · S | −3,961 | $80.44 | −$319K | 37,455 |
Loading...